Ishizawa, Tetsuya Makino, Naohiko Matsuda, Akiko Kakizaki, Yasuharu Kobayashi, Toshikazu Ikeda, Chisaki Sugahara, Shinpei Tsunoda, Michihiko Ueno, Yoshiyuki The detection rates of mutations of <i>KRAS</i>, <i>TP53</i>, <i>CDKN2A</i>, and <i>SMAD4</i>. <p>The detection rates of mutations of <i>KRAS</i>, <i>TP53</i>, <i>CDKN2A</i>, and <i>SMAD4</i>.</p> KRAS mutation analysis;retrospective study Pancreatic cancer;2A;2017. DNA sequences;cancer gene panel testing;SMAD;CDKN;endoscopic ultrasound-guided fine-needle aspiration;polymerase chain reaction;NGS;ROSE specimens;unresectable PC patients;5- year survival rate;KRAS mutations;TP;Ion AmpliSeq Comprehensive Caner Panel 2020-01-30
    https://plos.figshare.com/articles/figure/The_detection_rates_of_mutations_of_i_KRAS_i_i_TP53_i_i_CDKN2A_i_and_i_SMAD4_i_/11772753
10.1371/journal.pone.0228565.g002